Bank of Nova Scotia vs Twist Bioscience Corp — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Bank of Nova Scotia is far larger — about 14× Twist Bioscience Corp's market cap, and Bank of Nova Scotia pays a 3.64% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| BNS | TWST | |
|---|---|---|
Market Cap | $108.32B | $7.72B |
Sector | Financials | Health |
52-Week High | $90.29 | $124.88 |
52-Week Low | $56.41 | $24.16 |
Dividend Yield | 3.64% | — |
Enterprise Value | — | $7.65B |
Trailing returns across standard periods
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →